More Than 60 Industry Leaders to Speak at 2002 Pharmaceutical Marketing Congress in Philadelphia 6/17/2002
From: Matt Godson of the Institute for International Research, 212-661-3500, ext. 3225, mgodson@iirusa.com NEW YORK, June 17 -- Pharmaceutical marketers and industry professionals will gain insights from more than 60 industry thought leaders at the 2002 Pharmaceutical Marketing Congress, premiering Sept. 30 to Oct. 2, at the Wyndham Franklin Plaza Hotel in Philadelphia. The Congress will present the latest pharmaceutical marketing strategies, trends and technologies for marketing effectively and responsibly to consumers, professionals and managed markets. "The pharmaceutical industry has entered an era riddled with greater challenges than ever before, with $35 billion worth of products coming off patent by 2005, greater generic competition, less-than-prolific pipelines and intensifying cost-containment pressures," said Yvonne Honigsberg, senior conference director of the Institute for International Research (IIR), event organizer. "The success of pharmaceutical companies increasingly depends on their ability to reach, build and fortify relationships more effectively with all customer groups. This premier industry event is designed to help pharmaceutical marketing professionals maintain a competitive advantage, gain insights from industry leaders and forge new industry relationships." This singular event will explore how pharmaceutical companies can best conduct progressive and effective marketing campaigns, forge valuable partnerships and develop powerful brands, while successfully addressing the needs of consumers, providers, payors, legislators and the health care community. Programs are designed for all members of brand and product teams, as well as senior-level marketing, sales, strategic planning and business development executives, and communications professionals. The Pharmaceutical Marketing Congress features keynote addresses by top industry leaders, plenary sessions, interactive workshops, panel discussions and case-based presentations, as well as exhibits and receptions. The distinguished keynote speakers include: -- J. Patrick Kelly, senior vice president, Worldwide Marketing, Pfizer -- Nancy Lurker, senior vice president, Marketing, Pharmacia -- Dr. Francois Nader, senior vice president, Medical Affairs, Aventis -- Derek Williams, senior vice president, Global Strategic Marketing, Bayer Pharmaceuticals. Among the more than 60 conference speakers are senior-level marketing and business executives from Pfizer, Eli Lilly & Co., Johnson & Johnson, Novartis, Bristol-Myers Squibb, Pharmacia, AstraZeneca, Roche, Boehringer Ingelheim, Purdue Pharma and Tap Pharmaceuticals. "The 2002 Pharmaceutical Marketing Congress comes from the leading industry event organizers, and is poised to become the industry's premier pharmaceutical marketing event," said Tom Larranaga, publisher, Pharmaceutical Executive. "With a top-caliber program and an impressive roster of speakers addressing the most pertinent issues for pharmaceutical marketing executives today, the event will undoubtedly be a cut above the rest." The principal event sponsor is SAP (e-business software solutions), executive sponsor is Accenture (management and technology services), supporting sponsors are Braun Consulting, Inc. and IMS Health. The official conference publication is Pharmaceutical Executive; Forbes is business media partner. For more information and registration, visit http://www.pharmaevent.com or call 888-670-8200 or 212-661-3500. About IIR The International Institute of Research (IIR) is the world's leading knowledge and skills transfer company with a global network of 44 companies and 109 operating units. IIR works with more than 600,000 business executives annually, providing them with knowledge and skills through training, conferences, seminars, e-learning, blended solutions, publications, exhibitions, consulting and mentoring. Visit the Web site at http://www.iir-global.com. | |